The Discounted Cash Flow (DCF) valuation of Pharma Research Products Co Ltd (214450.KQ) is 428,956.69 KRW. With the latest stock price at 680,000.00 KRW, the upside of Pharma Research Products Co Ltd based on DCF is -36.9%.
Based on the latest price of 680,000.00 KRW and our DCF valuation, Pharma Research Products Co Ltd (214450.KQ) is a sell. selling 214450.KQ stocks now will result in a potential gain of 36.9%.
| Range | Selected | |
| WACC / Discount Rate | 6.0% - 9.1% | 7.6% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 263,519.58 - 1,163,842.67 | 428,956.69 |
| Upside | -61.2% - 71.2% | -36.9% |